Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasudil in Raynaud's Phenomenon
NCT00498615Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2007
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fasudil in Raynaud phenomenon (3 arms), sponsored by Johns Hopkins University. Primary endpoints: Time to Recover 50% of Fall in the Baseline Skin Temperature at 60 minutes and Time to Recover to 70% of Fall in the Baseline Skin Temperature After Cold Challenge at 60 minutes. Started Apr 2007; status: completed.
02
Drugs
fasudil
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT00498615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498615.